Advanced Debt To Assets from 2010 to 2026

ADVB Stock   0.30  0.01  2.24%   
Advanced Biomed's Debt To Assets are increasing over the years with stable fluctuation. Debt To Assets are expected to dwindle to 0.0002. From 2010 to 2026 Advanced Biomed Debt To Assets quarterly data regression line had arithmetic mean of  0.01 and r-squared of  0.05. View All Fundamentals
 
Debt To Assets  
First Reported
2010-12-31
Previous Quarter
0.000223
Current Value
0.000212
Quarterly Volatility
0.01944685
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Advanced Biomed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Advanced Biomed's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 64.6 K or Interest Income of 64.6 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.0048. Advanced financial statements analysis is a perfect complement when working with Advanced Biomed Valuation or Volatility modules.
  
Build AI portfolio with Advanced Stock
Check out the analysis of Advanced Biomed Correlation against competitors.

Latest Advanced Biomed's Debt To Assets Growth Pattern

Below is the plot of the Debt To Assets of Advanced Biomed Common over the last few years. It is Advanced Biomed's Debt To Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Advanced Biomed's overall financial position and show how it may be relating to other accounts over time.
Debt To Assets10 Years Trend
Pretty Stable
   Debt To Assets   
       Timeline  

Advanced Debt To Assets Regression Statistics

Arithmetic Mean0.01
Geometric Mean0.01
Coefficient Of Variation142.51
Mean Deviation0.01
Median0.01
Standard Deviation0.02
Sample Variance0.0004
Range0.0708
R-Value0.21
Mean Square Error0.0004
R-Squared0.05
Significance0.41
Slope0.0008
Total Sum of Squares0.01

Advanced Debt To Assets History

2026 2.12E-4
2025 2.23E-4
2024 1.94E-4
2023 0.0288
2022 0.0527
2021 0.071

About Advanced Biomed Financial Statements

Advanced Biomed stakeholders use historical fundamental indicators, such as Advanced Biomed's Debt To Assets, to determine how well the company is positioned to perform in the future. Although Advanced Biomed investors may analyze each financial statement separately, they are all interrelated. For example, changes in Advanced Biomed's assets and liabilities are reflected in the revenues and expenses on Advanced Biomed's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Advanced Biomed Common. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Advanced Biomed Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Advanced Biomed's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Advanced Biomed Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Advanced Biomed Common Stock:
Check out the analysis of Advanced Biomed Correlation against competitors.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Advanced Biomed. If investors know Advanced will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Advanced Biomed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.17)
Return On Assets
(0.35)
Return On Equity
(1.65)
The market value of Advanced Biomed Common is measured differently than its book value, which is the value of Advanced that is recorded on the company's balance sheet. Investors also form their own opinion of Advanced Biomed's value that differs from its market value or its book value, called intrinsic value, which is Advanced Biomed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Advanced Biomed's market value can be influenced by many factors that don't directly affect Advanced Biomed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Advanced Biomed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Advanced Biomed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Advanced Biomed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.